跳至主要内容
临床试验/ITMCTR2200005751
ITMCTR2200005751尚未招募1 期

Efficacy and safety of acupuncture at Different depths of Qugu Acupoint in the treatment of benign prostatic hyperplasia: a randomized controlled trial

Xiyuan Hospital of China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
50 至 80(—)
性别
Male

入选标准

  • (1)It meets the diagnostic criteria of BPH and has been clearly diagnosed by a specialist;
  • (2)The age ranges from 50 to 80;
  • (3)Voluntary subjects who sign informed consent voluntarily.

排除标准

  • (1) Unable to communicate unobstructed;
  • (2) Associated with urethritis, acute prostatitis, urinary calculi and other diseases;
  • (3) Complicated with neurogenic bladder, bladder neck fibrosis, urethral stricture and other diseases;
  • (4) Patients with neurological diseases or diabetes that affect urination function;
  • (5) Hyperplasia of prostate complicated with malignant wasting diseases such as prostate cancer and tuberculosis;
  • (6) Patients with serious diseases such as liver and kidney insufficiency and other heart and lung diseases and blood diseases;
  • (7) Patients taking anticoagulants for a long time and patients with severe anemia;
  • (8) Patients with upper urinary tract obstruction and hydronephrosis and impaired renal function found by B-ultrasound;
  • (9) Have been using drugs that may affect bladder function or are receiving BPH drugs;
  • (10) B ultrasound or CT found excessive prostatic hyperplasia, protruding too much bladder, affecting acupuncture operators;
  • (11) B ultrasound or CT found that residual urine in the bladder was more than 100ml or too much, which affected the acupuncture operator.

研究者

相似试验

Efficacy and safety of acupuncture at Different... | 临床试验